A leading healthcare technology provider, offering blood center management solutions, was watching its own legacy platform slow down the very products it was trying to bring to market. A system built on more than 700 Oracle Forms, wrapped in complex business workflows, was extending product delivery timelines well beyond what the business could afford. A growing engineering backlog collided with a legacy architecture that simply couldn’t flex, limiting capacity for new product innovation right when the business needed to move faster, not slower. Regulatory compliance, traceability, and governance requirements, non-negotiable in this space, were slowing AI adoption across engineering workflows even as the rest of the industry moved ahead. The client needed to accelerate product launches without compromising quality, compliance, or operational continuity, a balance that’s difficult to strike even without a legacy system working against you.
Ascendion implemented AAVA to orchestrate specialized AI agents across the software engineering lifecycle, with built-in governance and human-in-the-loop oversight ensuring nothing shipped without the right eyes on it first.
Ascendion leveraged Spec-Driven Development to automate analysis, requirements, code generation, testing, and documentation, deploying AI agents across the engineering lifecycle to accelerate parallel development and improve productivity without cutting corners. Quality gates, traceability, and approval workflows were embedded throughout to ensure FDA compliance and production readiness at every stage, not bolted on at the end.
Tech Stack:
Accelerated modernization of 700+ Oracle Forms.
Reduced product launch timeline from 21 months to 10 months.
Significantly reduced manual analysis and documentation effort through AI-assisted automation.
Accelerated engineering velocity and faster time-to-market, enabling earlier revenue realization.
Improved consistency, traceability, and quality across requirements, code, and testing.
Strengthened FDA compliance and governance with human-reviewed AI outputs and complete auditability.
